Condition 1: Retained placenta. Condition 2: Retained placenta. Condition 3: Retained placenta. Retained placenta without haemorrhage Morbidly adherent placenta Sequelae of complication of pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention 1: Intervention group: sublingual prescription of two 0.5 milligram tablets of nitroglycerin. Intervention 2: Control group: sublingual prescription of two tablets of placebo.
Treatment - Drugs
Intervention group: sublingual prescription of two 0.5 milligram tablets of nitroglycerin.
Control group: sublingual prescription of two tablets of placebo.
Sponsors
Vice chancellor for research ,Iran University of Medical Sciences.
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : maternal age between 18- 40; gestational age of 26 completed weeks and more; singleton; vaginal delivery and no placental delivery up to 30 minutes after neonatal birth despite of intramuscular oxitocine prescription and controlled cord traction . Exclusion criteria: any known systemic disorders; severe bleeding; known uterine malformations and suspicion for placenta accreta.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delivery of retained placenta. Timepoint: 5 minutes after prescription. Method of measurement: Data sheets. | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount of bleeding. Timepoint: the day after delivery. Method of measurement: hemoglobin concentration. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Kashanian
Iran University of Medical Sciences
Outcome results
None listed